Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The Challenge of Valuing Patents and Early‐State Technologies

The Challenge of Valuing Patents and Early‐State Technologies The enormous risk of commercializing inventions is not captured by standard valuation models and can cause their results to be wildly misleading. As a consequence, the valuation results seem irrelevant to managers and investors, and the models are not used in key business decisions. This article is about building relevant valuation models for patents and early‐stage technologies. The importance of valuing innovation goes beyond the details of dueling models. Numerous academic studies have placed innovation at the center of economic growth. Improved valuation models for patents and early‐stage technologies can help to attract capital and facilitate transactions, thereby strengthening incentives for innovation. As this review demonstrates, however, valuing patents and early‐stage technologies is a difficult problem with no easy answer. One must choose and then customize a model to match the salient features of the application—and even then, the analysis will often provide at best a range of possible values. But even if quantitative real options models are likely to be of limited use in many cases, real options thinking has a major role to play in both “framing” the valuation and guiding the management of patents and early‐stage technologies. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Applied Corporate Finance Wiley

The Challenge of Valuing Patents and Early‐State Technologies

Journal of Applied Corporate Finance , Volume 17 (2) – Mar 1, 2005

Loading next page...
 
/lp/wiley/the-challenge-of-valuing-patents-and-early-state-technologies-HwbKZHxp0R

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Wiley
Copyright
Copyright © 2005 Wiley Subscription Services, Inc., A Wiley Company
ISSN
1078-1196
eISSN
1745-6622
DOI
10.1111/j.1745-6622.2005.00033.x
Publisher site
See Article on Publisher Site

Abstract

The enormous risk of commercializing inventions is not captured by standard valuation models and can cause their results to be wildly misleading. As a consequence, the valuation results seem irrelevant to managers and investors, and the models are not used in key business decisions. This article is about building relevant valuation models for patents and early‐stage technologies. The importance of valuing innovation goes beyond the details of dueling models. Numerous academic studies have placed innovation at the center of economic growth. Improved valuation models for patents and early‐stage technologies can help to attract capital and facilitate transactions, thereby strengthening incentives for innovation. As this review demonstrates, however, valuing patents and early‐stage technologies is a difficult problem with no easy answer. One must choose and then customize a model to match the salient features of the application—and even then, the analysis will often provide at best a range of possible values. But even if quantitative real options models are likely to be of limited use in many cases, real options thinking has a major role to play in both “framing” the valuation and guiding the management of patents and early‐stage technologies.

Journal

Journal of Applied Corporate FinanceWiley

Published: Mar 1, 2005

There are no references for this article.